InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B 16 Nov 2016 3:36PM $0.380 $0.010 fallen by 97.37%
- BNO to Present at Society for Neuroscience Annual Meeting 16 Nov 2016 10:28AM $0.405 $0.010 fallen by 97.53%
- Final Director's Interest Notice 10 Nov 2016 3:43PM $0.410 $0.010 fallen by 97.56%
- Results of Meeting 8 Nov 2016 5:39PM $0.380 $0.010 fallen by 97.37%
- CEO & Managing Director's Report to Shareholders 8 Nov 2016 2:32PM $0.380 $0.010 fallen by 97.37%
- Chairman's Address Bionomics Annual General Meeting 2016 8 Nov 2016 2:27PM $0.380 $0.010 fallen by 97.37%
- Appendix 3B 4 Nov 2016 3:43PM $0.355 $0.010 fallen by 97.18%
- Bionomics and MSD Annual Symposium 4 Nov 2016 10:04AM $0.350 $0.010 fallen by 97.14%
- Appendix 4C - quarterly 31 Oct 2016 12:05AM $0.375 $0.010 fallen by 97.33%
- BNO to Present at International Biotechnology Symposium 25 Oct 2016 10:08AM $0.400 $0.010 fallen by 97.50%
- Upcoming Investor Presentations 24 Oct 2016 10:06AM $0.425 $0.010 fallen by 97.65%
- Appendix 4G / Corporate Governance Statement 7 Oct 2016 3:52PM $0.445 $0.010 fallen by 97.75%
- Bionomics Annual Report 2016 7 Oct 2016 3:50PM $0.445 $0.010 fallen by 97.75%
- Notice of General Meeting/Proxy Form 7 Oct 2016 3:47PM $0.445 $0.010 fallen by 97.75%
- Change of Director's Interest Notice 6 Oct 2016 11:17AM $0.430 $0.010 fallen by 97.67%
- Appendix 3B 6 Oct 2016 11:09AM $0.430 $0.010 fallen by 97.67%
- BNO to Present at Ladenburg Thalmann Healthcare Conference 26 Sep 2016 10:08AM $0.375 $0.010 fallen by 97.33%
- BNO BNC210 GAD Trial Results Investor Call Replay 22 Sep 2016 10:17AM $0.405 $0.010 fallen by 97.53%
- Positive BNC210 Phase 2 Anxiety Trial Results 21 Sep 2016 9:07AM $0.265 $0.010 fallen by 96.23%
- Trading Halt 19 Sep 2016 11:08AM $0.265 $0.010 fallen by 96.23%
- BNC210 Data to be Presented at ECNP 16 Sep 2016 10:23AM $0.270 $0.010 fallen by 96.30%
- Change of Director's Interest Notice 15 Sep 2016 3:42PM $0.270 $0.010 fallen by 96.30%
- BNO to Present at Rodman & Renshaw Global Investment Conf. 12 Sep 2016 10:24AM $0.290 $0.010 fallen by 96.55%
- S&P DJ Indices Announces September Quarterly Rebalance 2 Sep 2016 8:23AM $0.250 $0.010 fallen by 96%
- Change of Director's Interest Notice 1 Sep 2016 3:46PM $0.255 $0.010 fallen by 96.08%

426 - 450 of 801 results

Page 18 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.